Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Takeda buys stake in Enterome’s microbiome Crohn’s drug
Takeda has paid $50 million (€44 million) upfront to co-develop Enterome’s early-phase Crohn’s disease candidate EB8018.
U.S. scientists create new drug to sustain oxygen-starved hearts
SAN FRANCISCO, Oct.
Phase II trial of capmatinib demonstrates positive results in NSCLC
Novartis said that the phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) has demonstrated positive results in patients with MET mutated advanced non-small cell lun...
Molecule-level 'CT scans' could lead to faster drug discovery
Scientists like to use x-rays when determining chemical structures to develop drugs, but it's an agonizingly slow process.
No sweat required: Team finds hypertension treatment that mimics effect of exercise
Hypertension researchers at The University of Toledo have shown that by increasing the body's supply of beta hydroxybutyrate, a chemical produced predominantly by the liver, it is possible to regu...
Omega-3 Fatty Acids: Health Benefits And Sources
In recent decades, researchers and the general public have placed more significance on omega-3 fatty acids, consuming them from dietary sources or looking into fish oil supplements.
Chinese pharmacists fined $1.3 billion for a fake vaccine
The regulator also imposed a ban on working in the pharmaceutical sector for 14 managers.
Cost of blood pressure drug surges in U.S. after recall
NEW YORK (Reuters) - Prices for two dosages of the blood pressure drug valsartan rose more than any other drug in the United States in September, following a recall of much of the drug’s sup...
J&J's strong pharma unit sales offset currency rate woes in Q3
Johnson & Johnson's pharmaceutical business saw revenue increase 6.
Dr. Reddy's Laboratories Announces the Sale of Its API Manufacturing Business Unit in Jeedimetla, Hyderabad
HYDERABAD, India--(BUSINESS WIRE)--Dr.
FDA Advisory Committee Recommends Approval Of DSUVIA For The Treatment Of Moderate-To-Severe Acute Pain
REDWOOD CITY, Calif.
FDA Approves Talzenna for gBRCAm HER2– Breast Cancer
The FDA approved talazoparib (Talzenna, Pfizer), a poly(adenosine diphosphate–ribose) polymerase inhibitor, for patients with deleterious or suspected deleterious germline BRCA-mutat...
448
449
450
451
452
453
454
455
456